04.08.2014 • News

Sale of Emerald Performance Materials to American Securities Completed

Emerald Performance Materials announced that it has completed the sale of the company to an affiliate of private equity firm American Securities. Emerald has been an affiliated portfolio company of Sun Capital Partners since 2006.

Headquartered in Cuyahoga Falls, Ohio, Emerald's industry-leading brands serve a wide range of attractive end markets, including flavors and fragrances, food and beverage, personal and household care, composites, structural adhesives, coatings and plastics. The specialty chemical manufacturer's portfolio includes benzoic acid and derivatives such as fragrance ingredients and plasticizers, specialty resins, reactive liquid polymers and modifiers, antioxidants, accelerators, colorants, foam control products and other additives. Terms of the private transaction were not disclosed.

"We are excited about the completion of the sale of our company to American Securities and the opportunity to build upon the track record we have established," said Candy Wagner, president and chief financial officer of Emerald Performance Materials. "We are extremely proud of our accomplishments during our tenure as a Sun Capital Partners portfolio company - doubling the company's revenue and achieving a three-fold improvement in EBITDA. Emerald's employees are enthusiastic about the next step in our future and remain committed to continued innovation and growth of our company, while helping our customers and suppliers achieve their growth goals. We have many exciting opportunities ahead of us and look forward to this next phase as an affiliate of American Securities."

Emerald was formed in 2006 from the divesture of six specialty chemical businesses from Lubrizol and has since made four additional acquisitions in complementary businesses. Significant investments in new plant equipment have enabled the Company to expand capacity at its Rotterdam, Netherlands, and Kalama, Washington (U.S.) sites in order to meet increased customer demand for benzoic acid and down-stream specialty products such as non-phthalate plasticizers and fragrance ingredients. In addition, the company added assets at its Charlotte facility for expanded production of foam control and specialty silicone materials, increased capacity of its reactive modifiers at Maple Shade, New Jersey, and expanded R&D and pilot plant capabilities at Kalama, Cincinnati, Charlotte, Moorestown and Akron.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read